Crinetics Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CEOScott R. Struthers
CEOScott R. Struthers
Employees290
Employees290
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2008
Founded2008
Employees290
Employees290
CRNX Key Statistics
Market cap3.41B
Market cap3.41B
Price-Earnings ratio-9.58
Price-Earnings ratio-9.58
Dividend yield—
Dividend yield—
Average volume1.09M
Average volume1.09M
High today$38.95
High today$38.95
Low today$35.76
Low today$35.76
Open price$36.61
Open price$36.61
Volume1.61M
Volume1.61M
52 Week high$62.53
52 Week high$62.53
52 Week low$35.24
52 Week low$35.24
CRNX News
TipRanks 23h
Crinetics Pharmaceuticals Outlines 2025 Strategic PrioritiesStay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investme...
Analyst ratings
93%
of 14 ratingsBuy
92.9%
Hold
7.1%
Sell
0%